Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 24, 2024
10 Janeiro 2024 - 6:05PM
Business Wire
Elevance Health (NYSE: ELV) will release fourth quarter
and full year 2023 financial results on January 24, 2024 at 6:00
a.m. Eastern Daylight Time (“EDT”). Management will review these
results and its outlook during a conference call at 8:30 a.m. EDT
that same morning. The conference call should be accessed at least
15 minutes prior to its start with the following numbers:
- 888-947-9963 Access Code - 3972058 (Domestic)
- 312-470-0178 Access Code - 3972058 (International)
- 800-568-3942 No Access Code (Domestic Replay)
- 203-369-3812 No Access Code (International Replay)
The replay will be available from 11:30 a.m. EDT on January 24,
2024 until the end of the day on February 23, 2024. The call will
also be available through a live webcast at
www.elevancehealth.com under the “Investors” link. You may
also access the webcast here. A webcast replay will be
available following the call.
About Elevance Health, Inc.
Elevance Health is a lifetime, trusted health partner fueled by
its purpose to improve the health of humanity. The company supports
consumers, families, and communities across the entire care journey
– connecting them to the care, support, and resources they need to
lead healthier lives. Elevance Health’s companies serve
approximately 117 million people through a diverse portfolio of
industry-leading medical, digital, pharmacy, behavioral, clinical,
and complex care solutions. For more information, please visit
www.elevancehealth.com or follow us @ElevanceHealth on X and
Elevance Health on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240110733121/en/
Investor Relations: Stephen Tanal
Stephen.Tanal@elevancehealth.com
Media Relations: Leslie Porras
Leslie.Porras@elevancehealth.com
Elevance Health (NYSE:ELV)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Elevance Health (NYSE:ELV)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024